Cyclerion Therapeutics, Inc.
CYCN
$3.00
-$0.01-0.33%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.82M | 3.24M | 4.57M | 3.01M | 3.64M |
| Total Receivables | -- | 1.00M | 100.00K | 525.00K | 581.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 255.00K | 384.00K | 386.00K | 462.00K | 256.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 11.00K | 11.00K | 11.00K | 27.00K | 21.00K |
| Total Current Assets | 3.09M | 4.64M | 5.07M | 4.02M | 4.50M |
|
|
|||||
| Total Current Assets | 3.09M | 4.64M | 5.07M | 4.02M | 4.50M |
| Net Property, Plant & Equipment | 66.00K | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 8.51M | 9.99M | 10.42M | 9.37M | 9.85M |
|
|
|||||
| Total Accounts Payable | 457.00K | 508.00K | 480.00K | 462.00K | 483.00K |
| Total Accrued Expenses | 2.41M | 354.00K | 295.00K | 278.00K | 539.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 104.00K | 38.00K | 102.00K | 60.00K | 45.00K |
| Total Other Current Liabilities | 104.00K | 38.00K | 102.00K | 60.00K | 45.00K |
| Total Current Liabilities | 1.71M | 900.00K | 877.00K | 800.00K | 1.07M |
|
|
|||||
| Total Current Liabilities | 1.71M | 900.00K | 877.00K | 800.00K | 1.07M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.71M | 900.00K | 877.00K | 800.00K | 1.07M |
|
|
|||||
| Common Stock & APIC | 280.99M | 280.11M | 279.76M | 277.82M | 277.70M |
| Retained Earnings | -274.20M | -271.02M | -270.22M | -269.25M | -268.92M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 6.79M | 9.09M | 9.54M | 8.57M | 8.78M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 6.79M | 9.09M | 9.54M | 8.57M | 8.78M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 6.79M | 9.09M | 9.54M | 8.57M | 8.78M |
|
|
|||||